| Literature DB >> 34791597 |
Fanen Yuan1,2, Qian Sun1,2, Si Zhang1,2, Liguo Ye1,2, Yang Xu1,2, Zhou Xu1,2, Baohui Liu1,2, Shenqi Zhang3,4, Qianxue Chen5,6.
Abstract
Ferroptosis, as an new form of non-apoptotic regulated cell death, plays an important role in human cancers. Although it is reported that HSP27 is an novel regulator of ferroptosis in cancer, it remains unknown how HSP27 affects ferroptosis in glioma. In this study, we examined the effect of HSP27 on the ferroptosis of glioblasotma. HSP27 overexpression protects glioblastoma cells from erastin-induced ferroptosis while HSP27 depletion promotes erastin-induced ferroptosis of glioblastoma. Notably, HSP27 phosphorylation is required for the protective function of HSP27 in erastin-induced ferroptosis. Overall, our study reveal novel molecular mechanisms of ferroptosis in glioma and also identify HSP27 as a negative regulator of ferroptosis and a potential target for the treatment of glioma.Entities:
Keywords: Erastin; Ferroptosis; Glioblastoma; HSP27; Phosphorylation
Mesh:
Substances:
Year: 2021 PMID: 34791597 DOI: 10.1007/s13577-021-00645-6
Source DB: PubMed Journal: Hum Cell ISSN: 0914-7470 Impact factor: 4.174